HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Federico Bolognani Selected Research

apraglutide

1/2022Apraglutide, a novel once-weekly glucagon-like peptide-2 analog, improves intestinal fluid and energy absorption in patients with short bowel syndrome: An open-label phase 1 and 2 metabolic balance trial.
1/2022Apraglutide, a novel glucagon-like peptide-2 analog, improves fluid absorption in patients with short bowel syndrome intestinal failure: Findings from a placebo-controlled, randomized phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Federico Bolognani Research Topics

Disease

3Autism Spectrum Disorder
01/2019 - 01/2017
3Schizophrenia (Dementia Praecox)
07/2012 - 04/2006
2Short Bowel Syndrome
01/2022 - 01/2022
2Intestinal Failure
01/2022 - 01/2022
1Neoplasms (Cancer)
02/2013
1Liver Neoplasms (Liver Cancer)
10/2012
1Chronic Disease (Chronic Diseases)
07/2012
1Glioma (Gliomas)
02/2012
1Parkinson Disease (Parkinson's Disease)
11/2011
1Seizures (Absence Seizure)
12/2007
1Memory Disorders (Memory Loss)
05/2007

Drug/Important Bio-Agent (IBA)

2Glucagon (Glukagon)FDA Link
01/2022 - 01/2022
2apraglutideIBA
01/2022 - 01/2022
2Proteins (Proteins, Gene)FDA Link
02/2013 - 11/2011
2Antipsychotic Agents (Antipsychotics)IBA
07/2012 - 04/2006
2Glutamic Acid (Glutamate)FDA Link
07/2012 - 04/2006
2N-acetylaspartate (N-acetyl aspartate)IBA
07/2012 - 04/2006
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
07/2012 - 12/2009
2Phencyclidine (Angel Dust)IBA
07/2012 - 12/2009
2Glutamine (L-Glutamine)FDA Link
07/2012 - 04/2006
2Protons (Proton)IBA
07/2012 - 04/2006
1Vasopressin Receptors (Arginine Vasopressin Receptor)IBA
01/2019
1anti-NMDA receptor autoantibodyIBA
01/2017
1MicroRNAs (MicroRNA)IBA
02/2013
1Phenobarbital (Luminal)FDA Link
02/2013
1Messenger RNA (mRNA)IBA
02/2013
1Biomarkers (Surrogate Marker)IBA
02/2013
1CarcinogensIBA
10/2012
1N-Methylaspartate (NMDA)IBA
07/2012
1Excitatory Amino Acid AntagonistsIBA
07/2012
1RNA (Ribonucleic Acid)IBA
02/2012
1Phosphotransferases (Kinase)IBA
11/2011
1Leucine (L-Leucine)FDA Link
11/2011
1GABA Plasma Membrane Transport ProteinsIBA
12/2009
1EnzymesIBA
12/2009
1GABA-A Receptors (GABA(A) Receptor)IBA
12/2009
1gamma-Aminobutyric Acid (GABA)IBA
12/2009
1GAP-43 Protein (GAP 43 Protein)IBA
12/2007
1RNA-Binding Proteins (RNA-Binding Protein)IBA
05/2007
1Haloperidol (Haldol)FDA LinkGeneric
04/2006

Therapy/Procedure

1Therapeutics
01/2019
1Activities of Daily Living (ADL)
11/2018